Connection

John Gnann to Incidence

Back to Details
This is a "connection" page, showing publications John Gnann has written about Incidence.
John Gnann
Connection Strength
0.190
Incidence
  1. Herpes zoster in the age of focused immunosuppressive therapy. JAMA. 2009 Feb 18; 301(7):774-5.
    View in: PubMed
    Score: 0.060
  2. The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001. Clin Infect Dis. 2007 Oct 01; 45(7):881-2.
    View in: PubMed
    Score: 0.054
  3. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus. Clin Infect Dis. 2000 Apr; 30 Suppl 1:S72-6.
    View in: PubMed
    Score: 0.032
  4. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012 Apr; 54(7):922-8.
    View in: PubMed
    Score: 0.018
  5. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S207-15.
    View in: PubMed
    Score: 0.014
  6. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 02; 352(22):2271-84.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.